Last updated at 10 May 2025 10:08 PM
Director
DIN: 03563317
Paramasivam Anand is currently associated with 2 companies in various capacities such as Individual Promoter and Whole-time director. They serve as a Director at GALENGEN LIFESCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03563317.Paramasivam Anand is currently involved in 2 different roles. Their most recent position is with KAIZEN HEALTHSCIENCES PRIVATE LIMITED as a Whole-time director. The first company Paramasivam Anand was appointed to was GALENGEN LIFESCIENCES PRIVATE LIMITED. Paramasivam Anand is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Paramasivam Anand is currently associated with 2 companies in various capacities such as Individual Promoter and Whole-time director. They serve as a Director at GALENGEN LIFESCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03563317.Paramasivam Anand is currently involved in 2 different roles. Their most recent position is with KAIZEN HEALTHSCIENCES PRIVATE LIMITED as a Whole-time director. The first company Paramasivam Anand was appointed to was GALENGEN LIFESCIENCES PRIVATE LIMITED. Paramasivam Anand is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GALENGEN LIFESCIENCES PRIVATE LIMITED | Individual Promoter | 20-Aug-2021 |
| GALENGEN LIFESCIENCES PRIVATE LIMITED | Whole-time director | 20-Aug-2021 |
| KAIZEN HEALTHSCIENCES PRIVATE LIMITED | Whole-time director | 05-May-2025 |